# First-in-human study of the novel fibroblast activation protein-targeted 4-1BB agonist RO7122290 in patients with advanced solid tumors

## Supplementary source code

### Authors

- Mariana Bustamante<sup>1</sup>
- Eveline Nueesch<sup>1</sup>
- Chiahuey Ooi<sup>1</sup>
- Iakov I. Davydov<sup>1</sup>

1. Roche Pharma Research and Early Development, Roche Innovation Center Basel; Basel, Switzerland

Would like to thank Nicolas Staedler who provided some of the codes used for analysis.
